The clinical trial was a multicenter, practice-based, open-label study lasting 12 weeks. The objective of the study was to assess the utility of perindopril monotherapy administered once a day in ...
Description: The goal of the trial was to evaluate perindopril compared with placebo in patients age ≥70 years with clinical congestive heart failure (CHF) and preserved left ventricular systolic ...
On March 11, 2020, the Federal Court of Appeal dismissed Apotex’s appeal of the Federal Court’s decision ordering Apotex to pay over $61M from an accounting of profits from Apotex’s infringement of ...
A decline in physical function with age is strongly associated with disability in later life. Although regular exercise increases muscle strength and slows functional decline, the majority of elderly ...
Servier and its related company ADIR were successful in another chapter of patent litigation relating to perindopril (Servier’s COVERSYL): the Federal Court again dismissed Apotex’s non-infringing ...
SAN FRANCISCO (CBS.MW) -- Shares of CV Therapeutics rose 6.2 percent in after-hours trading Wednesday after the company said a study which included its Perindopril product has shown to be effective ...
Research suggests that lowering the blood pressure (BP) of patients with type 2 diabetes could reduce the risk of macrovascular and microvascular diabetic complications. Whether this strategy is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback